Your session is about to expire
← Back to Search
Other
Brewed kombucha tea for Diabetes
N/A
Waitlist Available
Led By Julie M Kapp, MPH, PhD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 hour
Summary
This trial is testing how drinking kombucha affects sugar processing in the body. It involves 20 people who will drink either kombucha or another beverage. The goal is to see if kombucha changes how the body handles sugar. Kombucha is a nonalcoholic, fermented tea beverage that has recently received negative attention because of documented concentrations of ethanol in excess of allowable limits of ≥0.5% alcohol by volume (ABV).
Eligible Conditions
- Diabetes
- High Blood Sugar
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Blood glucose level
Fasting blood glucose level
Fasting insulin level.
+1 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Intervention group 2: brewed kombuchaExperimental Treatment1 Intervention
8oz
Group II: Intervention group 1: commercial kombuchaExperimental Treatment1 Intervention
8oz
Group III: Control group 1: teaActive Control1 Intervention
8oz
Group IV: Control group 2: waterPlacebo Group1 Intervention
8oz
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Commercial kombucha tea
2019
N/A
~40
Brewed kombucha tea
2019
N/A
~40
Find a Location
Who is running the clinical trial?
University of Missouri-ColumbiaLead Sponsor
379 Previous Clinical Trials
628,523 Total Patients Enrolled
2 Trials studying Diabetes
136 Patients Enrolled for Diabetes
Julie M Kapp, MPH, PhDPrincipal InvestigatorUniversity of Missouri-Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You currently use any type of product that contains nicotine.You have been diagnosed with COPD (a chronic lung disease).You have a long-term problem with drinking too much alcohol.You have been diagnosed with peripheral vascular disease.Participants must be between the ages of 30 and 65, regardless of gender.You are able to travel to the study location.You have an autoimmune disease.You are pregnant or currently breastfeeding.You are considered overweight or obese based on your body mass index (BMI) being 25 or higher.You must be able to speak and understand English.You have been diagnosed with cancer.You have taken prebiotic or probiotic supplements in the last 3 months on a regular basis.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention group 1: commercial kombucha
- Group 2: Control group 1: tea
- Group 3: Intervention group 2: brewed kombucha
- Group 4: Control group 2: water
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger